- Home
- PSO vs PEN Comparison
PSO vs PEN Comparison
Compare PSO & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSO
- PEN
- Stock Information
- Founded
- PSO 1844
- PEN 2004
- Country
- PSO United Kingdom
- PEN United States
- Employees
- PSO N/A
- PEN N/A
- Industry
- PSO Books
- PEN Medical/Dental Instruments
- Sector
- PSO Consumer Discretionary
- PEN Health Care
- Exchange
- PSO Nasdaq
- PEN Nasdaq
- Market Cap
- PSO 9.5B
- PEN 9.7B
- IPO Year
- PSO 2000
- PEN 2015
- Fundamental
- Price
- PSO $13.13
- PEN $263.35
- Analyst Decision
- PSO
- PEN Strong Buy
- Analyst Count
- PSO 0
- PEN 16
- Target Price
- PSO N/A
- PEN $307.81
- AVG Volume (30 Days)
- PSO 747.8K
- PEN 419.3K
- Earning Date
- PSO 01-01-0001
- PEN 11-05-2025
- Dividend Yield
- PSO 2.48%
- PEN N/A
- EPS Growth
- PSO 31.65
- PEN 370.35
- EPS
- PSO 0.90
- PEN 4.14
- Revenue
- PSO $4,822,578,436.00
- PEN $1,333,798,000.00
- Revenue This Year
- PSO $2.17
- PEN $15.52
- Revenue Next Year
- PSO $5.10
- PEN $14.20
- P/E Ratio
- PSO $14.67
- PEN $63.94
- Revenue Growth
- PSO N/A
- PEN 14.61
- 52 Week Low
- PSO $13.07
- PEN $221.26
- 52 Week High
- PSO $17.90
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- PSO 26.69
- PEN 60.38
- Support Level
- PSO $13.63
- PEN $225.52
- Resistance Level
- PSO $13.82
- PEN $260.00
- Average True Range (ATR)
- PSO 0.16
- PEN 8.78
- MACD
- PSO -0.16
- PEN 0.41
- Stochastic Oscillator
- PSO 2.76
- PEN 82.95
About PSO Pearson Plc
Pearson PLC listed in the U.K., is an educational provider. The company has been divesting non-core businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centers on higher education, the firm also operates in providing clinical assessments, professional certification, and testing.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.